Cancer Channel
Topics
Medications
Quicklinks
Related Channels

Procrit Overdose

The production of red blood cells can be significantly increased if you take too much Procrit. Overdose effects (caused by the red blood cells increasing too quickly or too much) may include blood clots, congestive heart failure, heart attacks, or strokes. Treatment for a Procrit overdose usually involves removing blood or treating symptoms that occur as a result of the overdose.

Procrit Overdose: An Introduction

Procrit® (epoetin alfa) is a prescription medication used to treat anemia due to various causes. It is part of a group of medications known as erythropoiesis-stimulating agents (also known as ESAs). The effects of a Procrit overdose will vary, depending on a number of factors, including the Procrit dosage and whether it was taken with other medicines, alcohol, or street drugs. If you happen to overdose on Procrit, seek immediate medical attention.
 

Symptoms of a Procrit Overdose

Procrit works by stimulating the production of red blood cells. The expected symptoms of a Procrit overdose are caused by the red blood cells increasing too quickly or too much. This can be quite dangerous, increasing the risk of the following effects:
 

Treatment for a Procrit Overdose

If the red blood cells increase too much, this can be corrected by removing blood. This is done through the same process as that used when donating blood (except the blood is not donated). Treatment may also include supportive care, which consists of treating the symptoms that occur as a result of the overdose.
 
7 Natural Ways to Reduce Your Cancer Pain

Procrit Injection Information

Referring Pages:
Terms of Use
Advertise with Us
Contact Us
About eMedTV
Privacy Policy
Copyright © 2006-2017 Clinaero, Inc.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.